Why the study?
Does nifedipine GITS reduce cardiovascular mortality and morbidity compared to co-amilozide in older patients with hypertension and additional cardiovascular risk factors?
Does nifedipine GITS reduce cardiovascular mortality and morbidity compared to co-amilozide in older patients with hypertension and additional cardiovascular risk factors?
Nifedipine GITS is as effective as co-amilozide in preventing cardiovascular complications in high-risk hypertensive patients, highlighting that optimal blood pressure control is the primary determinant of outcomes.
No takes yet. Share an insight, caveat, or question.
Supports equivalent CV protection with nifedipine GITS vs co-amilozide in high-risk hypertension; confirms BP lowering as the primary outcome driver.
Morris J. Brown (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: